Eyam Health Inc. today announced the publication of peer-reviewed research in Nature Communications describing Gemini™, a ...
The Arvix BioMatrix™ platform is a modular biologic system comprising Base™, Core™, and Prime™ components designed to ...
With a budget of up to $20m, the collaboration will establish scalable, rapid manufacturing for recombinant-protein vaccines.
The Florida-based entrepreneur has helped build an eight-figure business while empowering clinic owners nationwide to ...
On Aug. 29, Medicare released its highly anticipated list of 10 therapies for which it plans to establish a price by 2026. The Inflation Reduction Act (IRA), passed in August 2022, gives Medicare ...
Oncodermatology is evolving with nonsurgical approaches and immune checkpoint inhibitors, improving outcomes in aggressive ...
GLP-1 therapies are a cornerstone for the management of type 2 diabetes, supporting glycemic control and improving ...
Chinese drugmaker Innovent Biologics and Eli Lilly plan to target cancer and immune system diseases under the partnership.
February 19-22 event in Sarasota, Florida features hands-on ultrasound training and sessions on emerging biologics, ...
The Nobel Prize in Medicine will never be awarded for excellence in the formulation and manufacture of biologic medicines. That’s understandable. Patients who need these medicines deserve the product ...
In patients with psoriasis, biologics may reduce ocular surface and corneal inflammation — especially dry eye, conjunctivitis ...
Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results